Given the important role of cyclin A1 and its functional link with ER-α and VEGF which have been identified in the present study, it is of interesting to investigate whether cyclin A1 may play an important in modulating treatment response of breast cancer in laboratory and clinical settings. This evidence concerns the gene VEGFA and breast cancer.